Innovation
54 patent families (39 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 6,743 times.
| Year | Filings |
|---|---|
| 2015 | 15 |
| 2016 | 18 |
| 2017 | 14 |
| 2018 | 16 |
| 2019 | 16 |
| 2020 | 15 |
| 2021 | 22 |
| 2022 | 13 |
| 2023 | 12 |
| 2024 | 14 |
| 2025 | 12 |
| 2026 | 4 |
Social engagement
Social engagement: 4.5K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
14 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 21% |
| Private equity | 1 | 7% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 9 | 64% |
Recent activity
13 May 2026
Milestone
regulatory
7 May 2026
Event
H.C. Wainwright & Co., LLC 4th Annual BioConnect Investor Conference and A.G.P./Alliance Global Partners Healthcare Company Showcase